Aura Biosciences, Inc. AURA

US Biotechnology

$7.58 ▼ -1.04% ($-0.08)

Open $7.63

Prev Close $7.66

Day Range $7.48 – $7.96

52W Range $4.73 – $9.54

Market Cap $794.38M

Beta 0.43

EPS (TTM) $-1.76

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-10-29
Shares Out.	103,700,000
Website	aurabiosciences.com ↗
Phone	13026587581
Employees	113
Revenue	$0
Gross Profit	$0
Net Income	-$45.6M
Free Cash Flow	-$103.4M
Total Assets	$348.1M
Total Liabilities	$32.9M
Equity	$315.3M

About Aura Biosciences, Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Aura Biosciences, Inc. is a publicly traded company under the ticker symbol AURA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.